Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027)

the ACCESS and SESSA Research Groups

Research output: Contribution to journalComment/debate

Abstract

The authors of the above paper have realized that an error has occurred in the number of eligible individuals selected and individuals who agreed to participate as below (page 142, 7th line of the paragraph immediately under “2.1. Study population”. (current) Of the 2994 eligible individuals selected, 1238 (1094 men) agreed to participate. (correct) Of the 2866 eligible individuals selected, 1236 (1094 men) agreed to participate. They assure that this error does not influence analyses, results, nor conclusions in the paper at all because all the analyses were conducted only for men, and therefore the number of study participants in the analyses is unchanged.

Original languageEnglish
Pages (from-to)336
Number of pages1
JournalAtherosclerosis
Volume278
DOIs
Publication statusPublished - 2018 Nov

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027)'. Together they form a unique fingerprint.

  • Cite this